Immunization News and Research

RSS

Uniform adoption of national HIV quality performance measures needed

To improve the quality of HIV care and treatment nationwide, 17 measures such as screening and prevention for infections and monitoring of antiretroviral therapy should be adopted uniformly, according to a work group led by a Kaiser Permanente researcher.

18 Aug 2010

Pharmacists in all states authorized to administer influenza vaccines

The American Pharmacists Association (APhA) is encouraging consumers to get immunized against influenza and to consider their local pharmacy as the site to receive their vaccine. Pharmacists in all 50 states including the District of Columbia are authorized to administer influenza vaccines and, as of June 30, 2010, more than 120,000 U.S. pharmacists have been trained to administer immunizations.

18 Aug 2010

Physician recommends vaccination for Meningitis before children start school

Freshmen all across the nation have begun packing in preparation for college. Along with their laptops, notebooks, pens and binders, there is one more essential item they need - a meningitis vaccination. "If a student hasn't gotten a meningitis vaccination, they absolutely should get one before they start school," said Dr. Michael Koller, associate professor of medicine, division of general internal medicine, Loyola University Chicago Stritch School of Medicine, Maywood. "Meningitis is not a common disease but it can be tragic."

18 Aug 2010

August is National Immunization and Cataract Awareness Month

Childhood immunizations keep our children safe from a number of serious diseases. This is a good time of year to make sure your child is up-to-date on all of his/her immunizations. Continue reading to find out which vaccines the Centers for Disease Control and Prevention (CDC) recommend for children 6 and under.

16 Aug 2010

Sinovac Biotech second-quarter 2010 sales increase 131% to $10.3 million

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and six-month periods ended June 30, 2010.

16 Aug 2010

International community must approach cancer as a global health priority

Once thought to be a problem primarily in the developed world, cancer is now a leading cause of death and disability in poorer countries. Almost two-thirds of the 7.6 million cancer deaths in the world occur in low- and middle-income countries.

16 Aug 2010

U.S. increases Pakistan flood aid contribution; Sen. Kerry to visit flood-hit Pakistan

"On assistance to Pakistan, to date, approximately $76 million in assistance has been provided by the U.S. to the flood-affected populations in Pakistan," Mark Toner, acting deputy spokesman for the State Department, said at a press briefing on Thursday, according to a transcript. "As of this morning, the additional money that the U.S. is providing is to Save the Children, and that's 4.1 million that will be used for food vouchers, enabling flood victims to purchase food in their local markets," he said.

16 Aug 2010

Human Immune Phenotyping Centers to receive NIAID grants for research

A new nationwide research initiative has been launched to define changes in the human immune system, using human and not animal studies, in response to infection or to vaccination. Six U. S.-based Human Immune Phenotyping Centers will receive a total of $100 million over five years to conduct this research.Funding for the centers is provided by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health. Support for the first year of this initiative will come from the American Recovery and Reinvestment Act.

12 Aug 2010

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

New study findings showed that a majority of patients with moderate to severe plaque psoriasis who had a previous response to STELARA® (ustekinumab) sustained a clinical response for up to three years with continued treatment regardless of their body weight. Investigators also presented findings from an integrated safety analysis that included data from one Phase 2 and three Phase 3 trials in which treatment with STELARA demonstrated a favorable benefit-risk profile for up to three years of treatment, consistent with previous analyses.

10 Aug 2010

MDinsight clinical quality system to help hospitals, physicians achieve meaningful use requirements

MDdatacor, Inc., a leader in health care quality management solutions for insurers and health care providers, today announced that its MDinsight clinical quality system will help hospitals and physicians achieve many of the meaningful use requirements as outlined in the recently announced final rules of the HITECH Act.

7 Aug 2010

Clinical trials in Asia, Africa confirm safety, effectiveness of rotavirus vaccine

Two studies published online Thursday in the Lancet show that the rotavirus vaccine is safe and effective at preventing much of the gastrointestinal illness in developing countries, where rotavirus kills more than 400,000 children under age 5 annually, Reuters reports. Based on the findings in Asia and Africa, the studies' authors "urged the governments of developing nations to make the vaccines a priority," the news service writes.

7 Aug 2010

Recent releases in Global Health

According to a Lancet Comment, "alcohol remains conspicuously absent from the larger field of research and programming in HIV and substance use. ... Patterns of hazardous alcohol consumption prevail in countries with the most severe HIV epidemics, notably eastern and southern Africa." In addition, "hazardous drinking patterns also dominate in the concentrated epidemics of eastern Europe and Asia, where alcohol use by injecting drug users and other marginalised groups might be an additional barrier to effective efforts to prevent HIV infection."

7 Aug 2010

Anti-vaccine group accused of unauthorized fundraising

The Australian Vaccination Network is involved in controversy yet again. The Bangalow-based anti-vaccination group has been given a timeline of 28 days to answer to claims that it breached charitable fundraising legislation on several occasions. It was only last month that the Health Care Complaints Commission had accused AVN of spreading misleading information about the dangers of immunization through its website.

5 Aug 2010

Telormedix, Swiss TPH Institute collaborate to develop effective vaccines for Malaria, Buruli Ulcer

Telormedix, a clinical stage biopharmaceutical company using targeted immunity to treat cancer and other diseases, today announced the start of a collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH) on a pilot study using Telormedix's adjuvant, TMX-201, in connection with immunization for Malaria and Buruli Ulcer.

3 Aug 2010

Merck reports strong bottom-line performance in second quarter

Merck & Co., Inc. today announced financial results for the second quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the second quarter of $0.86, which excludes purchase accounting adjustments, merger-related expenses, restructuring costs and the gain on AstraZeneca's asset option exercise. Second-quarter GAAP EPS was $0.24.

2 Aug 2010

Department of Health launches “Immunizations across the Lifespan” campaign

Secretary of Health Everette James today urged all Pennsylvanians to ensure they are fully immunized against vaccine-preventable diseases, noting that August is National Immunization Awareness Month.

31 Jul 2010

FDA announces approval of vaccines for 2010-2011 US influenza season

The U.S. Food and Drug Administration announced today that it has approved vaccines for the 2010-2011 influenza season in the United States.

31 Jul 2010

Sanofi Pasteur announces shipping of Fluzone Influenza Virus Vaccine in the U.S.

Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that shipping of the 2010-2011 formulation of its seasonal influenza vaccine Fluzone Influenza Virus Vaccine is underway in the U.S.

31 Jul 2010

GSK anticipates to supply over 30 million doses of FLULAVAL, FLUARIX for 2010-2011 flu season

GlaxoSmithKline announced today that the U.S. Food and Drug Administration's (FDA) Center for Biologics Evaluation and Research (CBER) has released the first lots of FluLaval® [Influenza Virus Vaccine] allowing distribution in the U.S. to begin for the 2010-2011 flu season. GSK anticipates distribution of Fluarix® [Influenza Virus Vaccine] to follow in the next several weeks.

30 Jul 2010

Vaccine scares may do more harm than previously believed to population's 'herd immunity'

Public immunization efforts may be much more sensitive than previously realized to small changes in the perceived costs or risks of vaccination, scientists at Harvard University report this week. In some cases, the spread of vaccine avoidance via social networks can make the difference between a minor, localized outbreak and an epidemic four times as large.

30 Jul 2010

Immunization News and Research

Uniform adoption of national HIV quality performance measures needed

Pharmacists in all states authorized to administer influenza vaccines

Physician recommends vaccination for Meningitis before children start school

August is National Immunization and Cataract Awareness Month

Sinovac Biotech second-quarter 2010 sales increase 131% to $10.3 million

International community must approach cancer as a global health priority

U.S. increases Pakistan flood aid contribution; Sen. Kerry to visit flood-hit Pakistan

Human Immune Phenotyping Centers to receive NIAID grants for research

Three-year efficacy data on STELARA for psoriasis presented at American Academy of Dermatology meeting

MDinsight clinical quality system to help hospitals, physicians achieve meaningful use requirements

Clinical trials in Asia, Africa confirm safety, effectiveness of rotavirus vaccine

Recent releases in Global Health

Anti-vaccine group accused of unauthorized fundraising

Telormedix, Swiss TPH Institute collaborate to develop effective vaccines for Malaria, Buruli Ulcer

Merck reports strong bottom-line performance in second quarter

Department of Health launches “Immunizations across the Lifespan” campaign

FDA announces approval of vaccines for 2010-2011 US influenza season

Sanofi Pasteur announces shipping of Fluzone Influenza Virus Vaccine in the U.S.

GSK anticipates to supply over 30 million doses of FLULAVAL, FLUARIX for 2010-2011 flu season

Vaccine scares may do more harm than previously believed to population's 'herd immunity'

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News